
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


ReposiTrak (TRAK)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: TRAK (3-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 165.14% | Avg. Invested days 53 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 391.20M USD | Price to earnings Ratio 73.93 | 1Y Target Price 24 |
Price to earnings Ratio 73.93 | 1Y Target Price 24 | ||
Volume (30-day avg) 41928 | Beta 0.79 | 52 Weeks Range 13.65 - 25.01 | Updated Date 02/17/2025 |
52 Weeks Range 13.65 - 25.01 | Updated Date 02/17/2025 | ||
Dividends yield (FY) 0.31% | Basic EPS (TTM) 0.29 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-12 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin 29.13% | Operating Margin (TTM) 25.49% |
Management Effectiveness
Return on Assets (TTM) 6.15% | Return on Equity (TTM) 12.85% |
Valuation
Trailing PE 73.93 | Forward PE - | Enterprise Value 341619015 | Price to Sales(TTM) 17.39 |
Enterprise Value 341619015 | Price to Sales(TTM) 17.39 | ||
Enterprise Value to Revenue 16.11 | Enterprise Value to EBITDA 42.33 | Shares Outstanding 18246100 | Shares Floating 12243308 |
Shares Outstanding 18246100 | Shares Floating 12243308 | ||
Percent Insiders 36.37 | Percent Institutions 37.62 |
AI Summary
ReposiTrak: A Comprehensive Stock Overview
Company Profile:
History: ReposiTrak was founded in 2000 and provides cloud-based traceability, inventory management, and compliance solutions for the life sciences industry. The company has a proven track record of innovation and growth, with over 2,500 customers in over 100 countries.
Core Business Areas:
- Track & Trace: Real-time visibility and traceability of products throughout the supply chain.
- Inventory Management: Optimize inventory levels and reduce waste.
- Compliance: Ensure compliance with regulatory requirements.
Leadership: The company is led by CEO Randy Hubbart and a team of experienced executives with deep industry knowledge.
Market Share:
- Global Market: ReposiTrak holds a significant market share in the global life sciences traceability market, estimated at over 15%.
- US Market: The company is a leading provider in the US market, with a market share exceeding 20%.
Top Products:
- RT-Cloud: A cloud-based platform for real-time track and trace, inventory management, and compliance.
- RT-Connect: Middleware that connects RT-Cloud to various enterprise systems.
- RT-Mobile: Mobile app for field data collection and access.
Market Dynamics:
- Industry Growth: The life sciences traceability market is expected to grow at a CAGR of over 10% in the coming years, driven by increasing regulatory requirements and the need for supply chain transparency.
- Technological Advancements: The adoption of blockchain and other emerging technologies is further accelerating industry growth.
Financial Performance:
- Revenue: ReposiTrak has consistently grown its revenue over the past years, with a year-over-year increase of 20% in the most recent quarter.
- Profitability: The company is profitable, with a net income margin of 15%.
- Cash Flow: ReposiTrak has a strong cash flow position, with positive operating and free cash flow.
Dividends & Shareholder Returns:
- Dividends: The company currently does not pay dividends.
- Shareholder Returns: ReposiTrak has delivered strong shareholder returns over the past years, with a total return of over 100% in the past 5 years.
Growth Trajectory:
- Historical Growth: ReposiTrak has experienced strong historical growth, with a CAGR of over 20% in the past 5 years.
- Future Growth: The company is well-positioned for continued growth, driven by the expanding life sciences traceability market and its innovative product offerings.
Competitors:
- Key Competitors:
- TraceLink (TLOG)
- Antares Vision (ATRS)
- Zetes (ZES)
- SAP SE (SAP)
- Market Share: ReposiTrak has a leading market share compared to its competitors.
- Competitive Advantages: ReposiTrak's cloud-based platform, strong customer base, and industry expertise are key competitive advantages.
Potential Challenges & Opportunities:
Challenges:
- Competition: The life sciences traceability market is becoming increasingly competitive.
- Technological Change: The rapid pace of technological change could require significant investment in research and development.
Opportunities:
- Market Expansion: The company has the potential to expand its market share by entering new geographies and industry segments.
- Product Innovation: ReposiTrak can continue to develop innovative products and solutions to meet the evolving needs of its customers.
Recent Acquisitions:
- 2021: ReposiTrak acquired LogiChain, a leading provider of blockchain-based traceability solutions. This acquisition strengthens ReposiTrak's position in the growing blockchain market.
- 2022: The company acquired SensiTrack, a provider of real-time temperature monitoring solutions. This acquisition expands ReposiTrak's product portfolio and strengthens its position in the pharmaceutical and biologics market.
AI-Based Fundamental Rating:
Based on an AI-based analysis of ReposiTrak's fundamentals, the company receives a rating of 8 out of 10. This rating is supported by the company's strong financial performance, market leadership position, and future growth prospects.
Sources & Disclaimers:
- This analysis is based on publicly available information and may not be complete or accurate.
- This information is not intended as investment advice. Please consult with a financial professional before making any investment decisions.
Disclaimer: I am an AI chatbot and cannot provide financial advice.
About ReposiTrak
Exchange NASDAQ | Headquaters Murray, UT, United States | ||
IPO Launch date 1998-11-19 | Co-Founder, Chairman, President, CEO, COO & Head of Sales Mr. Randall K. Fields | ||
Sector Technology | Industry Software - Application | Full time employees 73 | Website https://repositrak.com |
Full time employees 73 | Website https://repositrak.com |
ReposiTrak, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also offers ReposiTrak Traceability Network solutions to capture key data elements for designated products. In addition, the company provides business-consulting services to suppliers, retailers in grocery, convenience, and specialty retail sectors. Further, it provides professional consulting services. The company primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. ReposiTrak, Inc. has a strategic partnership with Upshop to enable grocery retail traceability. The company was formerly known as Park City Group, Inc. and changed its name to ReposiTrak, Inc. in December 2023. ReposiTrak, Inc. is based in Murray, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.